Loading...

Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients

Anti-HER2 agents, such as trastuzumab, lapatinib, trastuzumab emtansine (T-DM1), and pertuzumab, are standard agents in the treatment of breast cancer overexpressing the human epidermal growth factor receptor 2 (HER2). Trastuzumab is the first approved HER2-targeted agent. Subsequent developments in...

Full description

Saved in:
Bibliographic Details
Main Author: Sawaki, Masataka
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2014
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3998859/
https://ncbi.nlm.nih.gov/pubmed/24833915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S44047
Tags: Add Tag
No Tags, Be the first to tag this record!